title: Highlights of the San Antonio Breast Cancer Symposium 2015: part 2.
abstract: 38th San Antonio Breast Cancer Symposium (SABCS), San Antonio, TX, USA, 8-12 December 2015 The 38th annual San Antonio Breast Cancer Symposium was convened in San Antonio (TX, USA) on 8-12 December 2015. More than 7000 clinicians and scientists from around the world participated in the symposium, which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, loco-regional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with part 1 focusing on radiotherapy treatment, translational approaches to immunotherapy and longer term cardiotoxicity from anti-HER2 therapies. The second part of this report will discuss a range of topics including de-escalation of chemotherapy regimens in luminal A tumors, the prognostic relevance of circulating tumor cells, the optimum treatment of triple-negative breast cancer and shifting attitudes to primary surgical treatment.
authors.affiliation: Cambridge Breast Unit, Addenbrookes Hospital & University of Cambridge, Cambridge, UK.
authors.forename: John R
authors.initials: JR
authors.lastname: Benson
authors.affiliation: Division of Surgical Oncology, Dale H Dorn Chair in Surgery, University of Texas Health Science Centre, San Antonio, TX, USA.
authors.forename: Ismail
authors.initials: I
authors.lastname: Jatoi
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans
keywords: San Antonio; breast-conserving surgery; mastectomy; radiation treatment; triple-negative cancer